Evidence map›Paper›PMID 35070360›Full record

ArticleJournal of thoracic disease2021

Predictors of survival and technical success of bronchoscopic interventions in malignant airway obstruction.

Cláudia Freitas, Mariana Serino, Catarina Cardoso, Sandra Saleiro, Ana Paula Vaz, Hélder Novais-Bastos, António Morais, Adriana Magalhães, Gabriela Fernandes

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Interventional bronchoscopy in lung cancer treatment.Breathe (Sheffield, England) · 2024
    Review
  2. Article
  3. Review
  4. Overview of malignant central airway obstruction.Mediastinum (Hong Kong, China) · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Cláudia FreitasDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
Mariana SerinoDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
Catarina CardosoDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
Sandra SaleiroDepartment of Pulmonology, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto) EPE, Rua Dr. António Bernardino de Almeida, Porto, Portugal.
Ana Paula VazDepartment of Pulmonology, Unidade de Saúde Local de Matosinhos - Hospital Pedro Hispano, Rua Dr. Eduardo Torres, Senhora da Hora, Portugal.
Hélder Novais-BastosDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
António MoraisDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
Adriana MagalhãesDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
Gabriela FernandesDepartment of Pulmonology, Centro Hospitalar e Universitário São João, Alameda Prof. Hernani Monteiro, Porto, Portugal.
Hospital de São João · PTUniversidade do Porto · PTHospital Pedro Hispano · PTIPO Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalignant airway obstruction (MAO) leads to quality of life impairment and increased mortality. Interventional bronchoscopy allows airway patency restoring, leading to a better survival. We investigated predictors of survival and successful bronchoscopic intervention among MAO patients.

methodsThis observational prospective study enrolled 100 patients who were newly diagnosed with MAO. Survival was estimated with Kaplan-Meier method and curves compared by log-rank test. Multivariate analyses were performed using Cox proportional hazard models. Univariate and multivariate logistic regression were used for odds ratio calculation.

resultsA proportion of 73% of the patients were male with a median age was 62.5 years (range, 21-88 years). Lung cancer was the most common primary malignancy (74%). The majority had single (61%), endoluminal (62%) lesions and were classified as grade III in Myer Cotton scale (57%). The most used techniques comprised mechanical debulking (n=81) and laser therapy (n=68). Twenty-two airway stents were placed. While eleven patients were considered untreatable, technical success was achieved in 78%. Haemorrhage was the most common acute complication (16%). No deaths occurred as a result of the procedure. Median global survival was 8 months. Adjusting for age and Eastern Cooperative Oncology Group Performance Status (ECOG), extrinsic compression or mixed airway obstructions [hazard ratio (HR) =2.075; P=0.012], successful bronchoscopic intervention (HR =0.468; P=0.025) and initiation of cancer treatment (HR =0.373; P=0.006) were independent predictors of survival. The absence of distal airway patency on thoracic CT was independently associated with failure of the intervention [odds ratio (OR) =0.013; P<0.001].

conclusionsInterventional bronchoscopy has proven to be an efficient and safe strategy to manage MAO patients. The patients who benefit the most in terms of survival are those with purely endoluminal lesions, in whom technical success was achieved and those whose cancer-specific treatment was initiated. Distal airway patency on thoracic CT predicts the technical success of bronchoscopic intervention.

Indexed as

airway stentingcancer careinterventional bronchoscopyMalignant airway obstruction (MAO)survival

Identifiers

PMID35070360
PMCPMC8743414
OpenAlexW3211420294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.